Guanylate binding protein 1 is a novel effector of EGFR-driven invasion in glioblastoma

Journal of Experimental Medicine

Volumn 208, Issue 13, 2011, Pages 2657-2673

  Li, Ming ^a   Mukasa, Akitake ^a   Inda, Maria del Mar ^a   Zhang, Jianhua ^b   Chin, Lynda ^b   Cavenee, Webster ^a   Furnari, Frank ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN 1; INTERSTITIAL COLLAGENASE; MITOGEN ACTIVATED PROTEIN KINASE P38; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE ACTIVATION; GENE OVEREXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; BRAIN NEOPLASMS; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; GTP-BINDING PROTEINS; HUMANS; MATRIX METALLOPROTEINASE 1; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; PROTEIN STRUCTURE, TERTIARY; RECEPTOR, EPIDERMAL GROWTH FACTOR; TRANSPLANTATION, HETEROLOGOUS;

EID: 84862909038     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20111102     Document Type: Article

References (53)

1. Angers-Loustau, A., R. Hering, T.E. Werbowetski, D.R. Kaplan, and R.F. Del Maestro. 2004. SRC regulates actin dynamics and invasion of malignant glial cells in three dimensions. Mol. Cancer Res. 2:595-605.
2. Armstrong, D.A., L.N. Phelps, and M.P. Vincenti. 2009. CCAAT enhancer binding protein-beta regulates matrix metalloproteinase-1 expression in interleukin-1beta-stimulated A549 lung carcinoma cells. Mol. Cancer Res. 7:1517-1524. http://dx.doi.org/10.1158/1541-7786.MCR-09-0082.
3. Battle, T.E., and D.A. Frank. 2002. The role of STATs in apoptosis. Curr. Mol. Med. 2:381-392. http://dx.doi.org/10.2174/1566524023362456.
4. Bellail, A.C., S.B. Hunter, D.J. Brat, C. Tan, and E.G. Van Meir. 2004. Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion. Int. J. Biochem. Cell Biol. 36:1046-1069. http://dx.doi.org/10.1016/j.biocel.2004.01.013.
5. Cai, X.M., B.B. Tao, L.Y. Wang, Y.L. Liang, J.W. Jin, Y. Yang, Y.L. Hu, and X.L. Zha. 2005. Protein phosphatase activity of PTEN inhibited the invasion of glioma cells with epidermal growth factor receptor mutation type III expression. Int. J. Cancer. 117:905-912. http://dx.doi.org/10.1002/ijc.21251.
6. Cancer Genome Atlas Research Network. 2008. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 455:1061-1068. http://dx.doi.org/10.1038/nature07385.
7. Cheng, Y.S., R.J. Colonno, and F.H. Yin. 1983. Interferon induction of fibroblast proteins with guanylate binding activity. J. Biol. Chem. 258:7746-7750.
8. Cury, P.R., V.C. de Araújo, F. Canavez, C. Furuse, K.R. Leite, and N.S. de Araújo. 2007. The effect of epidermal growth factor on matrix metalloproteinases and tissue inhibitors of metalloproteinase gene expression in cultured human gingival fibroblasts. Arch. Oral Biol. 52:585-590. http://dx.doi.org/10.1016/j.archoralbio.2006.11.006.
9. Demuth, T., L.B. Reavie, J.L. Rennert, M. Nakada, S. Nakada, D.B. Hoelzinger, C.E. Beaudry, A.N. Henrichs, E.M. Anderson, and M.E. Berens. 2007. MAP-ing glioma invasion: mitogen-activated protein kinase kinase 3 and p38 drive glioma invasion and progression and predict patient survival. Mol. Cancer Ther. 6:1212-1222. http://dx.doi.org/10.1158/1535-7163.MCT-06-0711.
10. Duan, Z., R. Foster, K.A. Brakora, R.Z. Yusuf, and M.V. Seiden. 2006. GBP1 overexpression is associated with a paclitaxel resistance phenotype. Cancer Chemother. Pharmacol. 57:25-33. http://dx.doi.org/10.1007/s00280-005-0026-3.
11. Ducray, F., A. Idbaih, A. de Reyniès, I. Bièche, J. Thillet, K. Mokhtari, S. Lair, Y. Marie, S. Paris, M. Vidaud, et al. 2008. Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile. Mol. Cancer. 7:41. http://dx.doi.org/10.1186/1476-4598-7-41.
12. Furnari, F.B., T. Fenton, R.M. Bachoo, A. Mukasa, J.M. Stommel, A. Stegh, W.C. Hahn, K.L. Ligon, D.N. Louis, C. Brennan, et al. 2007. Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev. 21:2683-2710. http://dx.doi.org/10.1101/gad.1596707.
13. Guenzi, E., K. Töpolt, E. Cornali, C. Lubeseder-Martellato, A. Jörg, K. Matzen, C. Zietz, E. Kremmer, F. Nappi, M. Schwemmle, et al. 2001. The helical domain of GBP-1 mediates the inhibition of endothelial cell proliferation by inflammatory cytokines. EMBO J. 20:5568-5577. http://dx.doi.org/10.1093/emboj/20.20.5568.
14. Guenzi, E., K. Töpolt, C. Lubeseder-Martellato, A. Jörg, E. Naschberger, R. Benelli, A. Albini, and M. Stürzl. 2003. The guanylate binding protein-1 GTPase controls the invasive and angiogenic capability of endothelial cells through inhibition of MMP-1 expression. EMBO J. 22:3772-3782. http://dx.doi.org/10.1093/emboj/cdg382.
15. Huang, H.S., M. Nagane, C.K. Klingbeil, H. Lin, R. Nishikawa, X.D. Ji, C.M. Huang, G.N. Gill, H.S. Wiley, and W.K. Cavenee. 1997. The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling. J. Biol. Chem. 272:2927-2935. http://dx.doi.org/10.1074/jbc.272.5.2927.
16. Ihle, J.N., B.A. Witthuhn, F.W. Quelle, K. Yamamoto, W.E. Thierfelder, B. Kreider, and O. Silvennoinen. 1994. Signaling by the cytokine receptor superfamily: JAKs and STATs. Trends Biochem. Sci. 19:222-227. http://dx.doi.org/10.1016/0968-0004(94)90026-4.
17. Ishizawar, R., and S.J. Parsons. 2004. c-Src and cooperating partners in human cancer. Cancer Cell. 6:209-214. http://dx.doi.org/10.1016/j.ccr .2004.09.001.
18. Itoh, M., T. Murata, T. Suzuki, M. Shindoh, K. Nakajima, K. Imai, and K. Yoshida. 2006. Requirement of STAT3 activation for maximal collagenase-1 (MMP-1) induction by epidermal growth factor and malignant characteristics in T24 bladder cancer cells. Oncogene. 25:1195-1204. http://dx.doi.org/10.1038/sj.onc.1209149.
19. Kim, T.H., L.O. Barrera, and B. Ren. 2007. ChIP-chip for genome-wide analysis of protein binding in mammalian cells. Curr. Protoc. Mol. Biol. Chapter 21:Unit 21.13.
20. Kovarik, P., D. Stoiber, P.A. Eyers, R. Menghini, A. Neininger, M. Gaestel, P. Cohen, and T. Decker. 1999. Stress-induced phosphorylation of STAT1 at Ser727 requires p38 mitogen-activated protein kinase whereas IFN-gamma uses a different signaling pathway. Proc. Natl. Acad. Sci. USA. 96:13956-13961. http://dx.doi.org/10.1073/pnas.96.24.13956.
21. Lal, S., M. Lacroix, P. Tofilon, G.N. Fuller, R. Sawaya, and F.F. Lang. 2000. An implantable guide-screw system for brain tumor studies in small animals. J. Neurosurg. 92:326-333. http://dx.doi.org/10.3171/jns.2000.92.2.0326.
22. Leaman, D.W., S. Pisharody, T.W. Flickinger, M.A. Commane, J. Schlessinger, I.M. Kerr, D.E. Levy, and G.R. Stark. 1996. Roles of JAKs in activation of STATs and stimulation of c-fos gene expression by epidermal growth factor. Mol. Cell. Biol. 16:369-375.
23. Lew, D.J., T. Decker, I. Strehlow, and J.E. Darnell. 1991. Overlapping elements in the guanylate-binding protein gene promoter mediate transcriptional induction by ? and ? interferons. Mol. Cell. Biol. 11:182-191.
24. Li, M., S.S. Ng, J. Wang, L. Lai, S.Y. Leung, M. Franco, Y. Peng, M.L. He, H.F. Kung, and M.C. Lin. 2006. EFA6A enhances glioma cell invasion through ADP ribosylation factor 6/extracellular signal-regulated kinase signaling. Cancer Res. 66:1583-1590. http://dx.doi.org/10.1158/0008-5472.CAN-05-2424.
25. Libermann, T.A., H.R. Nusbaum, N. Razon, R. Kris, I. Lax, H. Soreq, N. Whittle, M.D. Waterfield, A. Ullrich, and J. Schlessinger. 1985. Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin. Nature. 313:144-147. http://dx.doi.org/10.1038/313144a0.
26. Lieskovska, J., Y. Ling, J. Badley-Clarke, and D.R. Clemmons. 2006. The role of Src kinase in insulin-like growth factor-dependent mitogenic signaling in vascular smooth muscle cells. J. Biol. Chem. 281:25041-25053. http://dx.doi.org/10.1074/jbc.M602866200.
27. Lu, K.V., S. Zhu, A. Cvrljevic, T.T. Huang, S. Sarkaria, D. Ahkavan, J. Dang, E.B. Dinca, S.B. Plaisier, I. Oderberg, et al. 2009. Fyn and SRC are effectors of oncogenic epidermal growth factor receptor signaling in glioblastoma patients. Cancer Res. 69:6889-6898. http://dx.doi.org/10.1158/0008-5472.CAN-09-0347.
28. Lubeseder-Martellato, C., E. Guenzi, A. Jörg, K. Töpolt, E. Naschberger, E. Kremmer, C. Zietz, E. Tschachler, P. Hutzler, M. Schwemmle, et al. 2002. Guanylate-binding protein-1 expression is selectively induced by inflammatory cytokines and is an activation marker of endothelial cells during inflammatory diseases. Am. J. Pathol. 161:1749-1759. http://dx.doi.org/10.1016/S0002-9440(10)64452-5.
29. Nagane, M., F. Coufal, H. Lin, O. Bögler, W.K. Cavenee, and H.J. Huang. 1996. A common mutant epidermal growth factor receptor confers enhanced tumorigenicity on human glioblastoma cells by increasing proliferation and reducing apoptosis. Cancer Res. 56:5079-5086.
30. Narita, Y., M. Nagane, K. Mishima, H.J. Huang, F.B. Furnari, and W.K. Cavenee. 2002. Mutant epidermal growth factor receptor signaling downregulates p27 through activation of the phosphatidylinositol 3-kinase/Akt pathway in glioblastomas. Cancer Res. 62:6764-6769.
31. Naschberger, E., T. Werner, A.B. Vicente, E. Guenzi, K. Töpolt, R. Leubert, C. Lubeseder-Martellato, P.J. Nelson, and M. Stürzl. 2004. Nuclear factor-kappaB motif and interferon-alpha-stimulated response element co-operate in the activation of guanylate-binding protein-1 expression by inflammatory cytokines in endothelial cells. Biochem. J. 379:409-420. http://dx.doi.org/10.1042/BJ20031873.
32. Nishikawa, R., X.D. Ji, R.C. Harmon, C.S. Lazar, G.N. Gill, W.K. Cavenee, and H.J. Huang. 1994. A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity. Proc. Natl. Acad. Sci. USA. 91:7727-7731. http://dx.doi.org/10.1073/pnas.91.16.7727.
33. Nutt, J.E., and J. Lunec. 1996. Induction of metalloproteinase (MMP1) expression by epidermal growth factor (EGF) receptor stimulation and serum deprivation in human breast tumour cells. Eur. J. Cancer. 32:2127-2135. http://dx.doi.org/10.1016/S0959-8049(96)00261-4.
34. Nutt, J.E., J.K. Mellon, K. Qureshi, and J. Lunec. 1998. Matrix metalloproteinase-1 is induced by epidermal growth factor in human bladder tumour cell lines and is detectable in urine of patients with bladder tumours. Br. J. Cancer. 78:215-220. http://dx.doi.org/10.1038/bjc.1998.467.
35. Palacios, D., C. Mozzetta, S. Consalvi, G. Caretti, V. Saccone, V. Proserpio, V.E. Marquez, S. Valente, A. Mai, S.V. Forcales, et al. 2010. TNF/p38α/polycomb signaling to Pax7 locus in satellite cells links inflammation to the epigenetic control of muscle regeneration. Cell Stem Cell. 7:455-469. http://dx.doi.org/10.1016/j.stem.2010.08.013.
36. Park, M.J., I.C. Park, J.H. Hur, M.S. Kim, H.C. Lee, S.H. Woo, K.H. Lee, C.H. Rhee, S.I. Hong, and S.H. Lee. 2002. Modulation of phorbol ester-induced regulation of matrix metalloproteinases and tissue inhibitors of metalloproteinases by SB203580, a specific inhibitor of p38 mitogen-activated protein kinase. J. Neurosurg. 97:112-118. http://dx.doi.org/10.3171/jns.2002.97.1.0112.
37. Pedersen, M.W., V. Tkach, N. Pedersen, V. Berezin, and H.S. Poulsen. 2004. Expression of a naturally occurring constitutively active variant of the epidermal growth factor receptor in mouse fibroblasts increases motility. Int. J. Cancer. 108:643-653. http://dx.doi.org/10.1002/ijc.11566.
38. Praefcke, G.J., S. Kloep, U. Benscheid, H. Lilie, B. Prakash, and C. Herrmann. 2004. Identification of residues in the human guanylate-binding protein 1 critical for nucleotide binding and cooperative GTP hydrolysis. J. Mol. Biol. 344:257-269. http://dx.doi.org/10.1016/j.jmb.2004.09.026.
39. Prakash, B., G.J. Praefcke, L. Renault, A. Wittinghofer, and C. Herrmann. 2000a. Structure of human guanylate-binding protein 1 representing a unique class of GTP-binding proteins. Nature. 403:567-571. http://dx.doi.org/10.1038/35000617.
40. Prakash, B., L. Renault, G.J. Praefcke, C. Herrmann, and A. Wittinghofer. 2000b. Triphosphate structure of guanylate-binding protein 1 and implications for nucleotide binding and GTPase mechanism. EMBO J. 19:4555-4564. http://dx.doi.org/10.1093/emboj/19.17.4555.
41. Ramsauer, K., I. Sadzak, A. Porras, A. Pilz, A.R. Nebreda, T. Decker, and P. Kovarik. 2002. p38 MAPK enhances STAT1-dependent transcription independently of Ser-727 phosphorylation. Proc. Natl. Acad. Sci. USA. 99:12859-12864. http://dx.doi.org/10.1073/pnas.192264999.
42. Rhodes, D.R., J. Yu, K. Shanker, N. Deshpande, R. Varambally, D. Ghosh, T. Barrette, A. Pandey, and A.M. Chinnaiyan. 2004. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia. 6:1-6.
43. Sarkaria, J.N., L. Yang, P.T. Grogan, G.J. Kitange, B.L. Carlson, M.A. Schroeder, E. Galanis, C. Giannini, W. Wu, E.B. Dinca, and C.D. James. 2007. Identification of molecular characteristics correlated with glioblastoma sensitivity to EGFR kinase inhibition through use of an intracranial xenograft test panel. Mol. Cancer Ther. 6:1167-1174. http://dx.doi.org/10.1158/1535-7163.MCT-06-0691.
44. Stojic, J., C. Hagemann, S. Haas, C. Herbold, S. Kühnel, S. Gerngras, W. Roggendorf, K. Roosen, and G.H. Vince. 2008. Expression of matrix metalloproteinases MMP-1, MMP-11 and MMP-19 is correlated with the WHO-grading of human malignant gliomas. Neurosci. Res. 60:40-49. http://dx.doi.org/10.1016/j.neures.2007.09.009.
45. Stupp, R., W.P. Mason, M.J. van den Bent, M. Weller, B. Fisher, M.J. Taphoorn, K. Belanger, A.A. Brandes, C. Marosi, U. Bogdahn, et al; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. 2005. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 352:987-996. http://dx.doi.org/10.1056/NEJMoa043330.
46. Summy, J.M., J.G. Trevino, C.H. Baker, and G.E. Gallick. 2005. c-Src regulates constitutive and EGF-mediated VEGF expression in pancreatic tumor cells through activation of phosphatidyl inositol-3 kinase and p38 MAPK. Pancreas. 31:263-274. http://dx.doi.org/10.1097/01.mpa.0000178280.50534.0c.
47. Sun, L., A.M. Hui, Q. Su, A. Vortmeyer, Y. Kotliarov, S. Pastorino, A. Passaniti, J. Menon, J. Walling, R. Bailey, et al. 2006. Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell. 9:287-300. http://dx.doi.org/10.1016/j.ccr.2006 .03.003.
48. Verhaak, R.G., K.A. Hoadley, E. Purdom, V. Wang, Y. Qi, M.D. Wilkerson, C.R. Miller, L. Ding, T. Golub, J.P. Mesirov, et al; Cancer Genome Atlas Research Network. 2010. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 17:98-110. http://dx.doi.org/10.1016/j.ccr.2009.12.020.
49. Wells, A. 1999. EGF receptor. Int. J. Biochem. Cell Biol. 31:637-643. http://dx.doi.org/10.1016/S1357-2725(99)00015-1.
50. Wen, Z., Z. Zhong, and J.E. Darnell Jr. 1995. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell. 82:241-250. http://dx.doi.org/10.1016/0092-8674(95)90311-9.
51. Wong, A.J., S.H. Bigner, D.D. Bigner, K.W. Kinzler, S.R. Hamilton, and B. Vogelstein. 1987. Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc. Natl. Acad. Sci. USA. 84:6899-6903. http://dx.doi.org/10.1073/pnas.84.19.6899.
52. Wong, A.J., J.M. Ruppert, S.H. Bigner, C.H. Grzeschik, P.A. Humphrey, D.S. Bigner, and B. Vogelstein. 1992. Structural alterations of the epidermal growth factor receptor gene in human gliomas. Proc. Natl. Acad. Sci. USA. 89:2965-2969. http://dx.doi.org/10.1073/pnas.89.7.2965.
53. Yao, Y.L., W.M. Yang, and E. Seto. 2001. Regulation of transcription factor YY1 by acetylation and deacetylation. Mol. Cell. Biol. 21:5979-5991. http://dx.doi.org/10.1128/MCB.21.17.5979-5991.2001.